Connie J Rackley Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5140 Highway 367 S, Mc Rae, AR 72102 Phone: 501-726-8080 Fax: 501-726-8081 |
Mr. Geoffrey M. Cuizon, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5140 Highway 367 S, Mc Rae, AR 72102 Phone: 501-726-8080 Fax: 501-726-8081 |
News Archive
Sepsis, a form of systemic inflammation, is the leading cause of death in critically ill patients. Sepsis is linked with massive cell death; however, the specific mechanisms involved in the lethality of sepsis are unclear. Now, a new study published by Cell Press in the December 23rd issue of the journal Immunity finds that inhibition of a specific cell death pathway called "necroptosis" protected mice from lethal inflammation.
Cells from heart attack survivors' own bone marrow reduced the risk of death or another heart attack when they were infused into the affected artery after successful stent placement, according to research reported in the American Heart Association journal Circulation: Heart Failure.
With strict social and legal restrictions associated with third party reproduction, as well as limited egg donors available in the UK, an increasing number of British couples are traveling to the U.S. for alternative fertility treatments, such as egg donation. Unfortunately, the UK does not allow financial compensation for egg donors; this greatly reduces the number of available donors and presents major obstacles for many infertile couples, some of whom wait for an egg donor for two years or longer. Last year approximately 1200 egg donors were needed in the UK, and roughly 500 families were unable to find a donor.
Finding out how kinesiophobia -unreasonable fear of movement- may affect individuals with chronic musculoskeletal pain is the aim of a research group of the University of Malaga, which recent studies have been published in the scientific journal British Journal of Sports Medicine, the world's number 1 publication in the locomotor system field.
Carl Zeiss Meditec, Inc. announced today that the MEL 80 Excimer Laser has received premarket approval from the U.S. Food and Drug Administration for the treatment of hyperopia.
› Verified 5 days ago